| Name | Title | Contact Details |
|---|---|---|
Ken Miller |
Chief Commercial Officer | Profile |
Thomas Adams |
Vice President of Financial Planning and Analysis | Profile |
Andrew LaFrence |
Chief Financial Officer | Profile |
Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Companys principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through ...
Galderma Canada Inc. is a Thornhill, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Challenge Printing Company, The is a Clifton, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.
SENN CHEMICALS is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.